Tempus AI, Inc.
NASDAQ:TEMMedical - Healthcare Information Services
-$1.77 today
- Market cap
- $11.28B
- Beta
- 3.62
- P/E (TTM)
- -28.8
- EPS (TTM)
- -$1.69
Volume 5.35M
Average 6.17M
TEM EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Tempus AI, Inc.NASDAQ: TEM
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA remains negative
Q3 FY2026 EBITDA was -$56.86M, compared with -$38.79M a year earlier. Trailing-twelve-month EBITDA was -$108.97M.
Context
- EBITDA amounted to 9.3% of revenue in FY2025, down 78.7 pp from a year earlier.
- EBITDA grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 15 analysts of $139.16M (+217.4%) for the fiscal year ending Dec 2026, a step up from the +80.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- -$56.86M-226.1% QoQ
- Last fiscal yearDec 2025
- -$118.51M+80.6% YoY
- LTMSep 2026
- -$108.97M-19.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -46.6% | +398.5% | +445.0 pp |
| 1 year | +80.6% | +217.4% | +136.8 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (118.51M) USD
- Year-over-year change
- +80.6%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (118.51M) | +80.6% |
| FY2024 | 2024-12-31 | (610.42M) | -357.8% |
| FY2023 | 2023-12-31 | (133.33M) | +43.7% |
| FY2022 | 2022-12-31 | (236.85M) | -7.9% |
| FY2021 | 2021-12-31 | (219.52M) | — |
EBITDA vs competitors
How TEM compares with its peers on the latest reported figures
- TEM's LTM Sep 2026 EBITDA of -$108.97M is the 8th highest of the 11 companies compared; the peer median is -$2.73M.
- Its year-over-year change of -19.4% is the 8th highest of 11, against a peer median of +3.0%.
- EBITDA amounts to 7.2% of revenue for TEM, versus a peer median of 24.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $2.3B | +7.7% | +6.4% | 19.4% | |
| LTM Jun 2026 | $1.36B | -23.6% | — | 30.3% | |
| LTM Jun 2026 | $703.39M | -1.6% | -2.7% | 33.5% | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | $50.25M | +362.6% | — | 12.6% |
| LTM Jun 2026 | $12.89M | +145.3% | — | 1.7% | |
| LTM Mar 2026 | -$18.34M | +33.2% | — | 19.1% | |
| LTM Mar 2026 | -$85.53M | -16.7% | — | 132.6% | |
| LTM Sep 2026 | -$108.97M | -19.4% | — | 7.2% | |
| LTM Jun 2026 | -$178.71M | +15.6% | — | 6.6% | |
| LTM Mar 2026 | -$334.2M | -423.0% | — | 40.3% | |
| LTM Sep 2026 | -$441.45M | -24.7% | — | 34.5% | |
| Peer median (excluding TEM) | -$2.73M | +3.0% | +1.8% | 24.9% | |
Competitors are the stored peer set for TEM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 257.85M | 320.67M | 531.82M | 693.4M | 1.27B |
| Cost of Revenue | 174.21M | 190.48M | 245.65M | 312.29M | 473.89M |
| Gross Profit | 83.64M | 130.19M | 286.18M | 381.11M | 797.9M |
| Gross Margin | 32.4% | 40.6% | 53.8% | 55.0% | 62.7% |
| Research & Development | 128.35M | 162.25M | 185.5M | 316.84M | 319.03M |
| Selling, General & Admin | 199M | 233.38M | 296.76M | 755.35M | 715.43M |
| Operating Expenses | 327.36M | 395.63M | 482.26M | 1.07B | 1.05B |
| Depreciation & Amortization | 23.88M | 30.41M | 33.33M | 37.25M | 102.32M |
| EBITDA | (219.52M) | (236.85M) | (133.33M) | (610.42M) | (118.51M) |
| EBITDA Margin | -85.1% | -73.9% | -25.1% | -88.0% | -9.3% |
| Operating Income | (243.71M) | (265.44M) | (196.08M) | (691.08M) | (252.87M) |
| Operating Margin | -94.5% | -82.8% | -36.9% | -99.7% | -19.9% |
| Interest Income | 623K | 3.03M | 7.6M | 11.08M | 12.63M |
| Interest Expense | 15.18M | 21.89M | 46.87M | 53.65M | 70.27M |
| Other Income / Expenses | (15.48M) | (24.3M) | (17.75M) | (14.46M) | (43.84M) |
| Income Before Tax | (259.19M) | (289.75M) | (213.83M) | (705.54M) | (296.71M) |
| Pre-Tax Margin | -100.5% | -90.4% | -40.2% | -101.8% | -23.3% |
| Income Tax Expense | 0 | 66K | 288K | 266K | (51.68M) |
| Net Income | (259.19M) | (289.81M) | (214.12M) | (705.81M) | (245.03M) |
| Net Margin | -100.5% | -90.4% | -40.3% | -101.8% | -19.3% |
| EPS (Basic) | (1.75) | (1.97) | (1.73) | (4.60) | (1.41) |
| EPS (Diluted) | (1.75) | (1.97) | (1.73) | (4.60) | (1.41) |
| Weighted Avg Shares | 169.88M | 169.88M | 154.17M | 162.12M | 174.26M |
| Weighted Avg Shares (Diluted) | 169.88M | 169.88M | 154.17M | 162.12M | 174.26M |
Tempus AI, Inc.
NASDAQ:TEM
Intrinsic Alpha fair value
Locked
Current Price
$63.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.